Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study

Clin Auton Res. 2005 Feb;15(1):51-3. doi: 10.1007/s10286-005-0225-3.

Abstract

We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients' satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Autonomic Nervous System Diseases / complications
  • Autonomic Nervous System Diseases / drug therapy*
  • Cholinesterase Inhibitors / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypotension, Orthostatic / drug therapy*
  • Hypotension, Orthostatic / etiology
  • Male
  • Middle Aged
  • Pyridostigmine Bromide / administration & dosage*
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Pyridostigmine Bromide